NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) announced today that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC confirming the company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2), the Minimum Bid Price Requirement, effectively closing the matter.
The company had previously been notified on May 6, 2025, that its common stock's closing bid price had fallen below the $1.00 per share minimum for 30 consecutive business days. Nasdaq granted NeuroOne a 180-day extension on November 4, 2025, extending the compliance deadline to May 4, 2026.
To address the deficiency, NeuroOne effected a 1-for-6 reverse stock split that became effective at 5:00 p.m. Eastern Time on April 15, 2026. The company’s common stock began trading on a split-adjusted basis at the market open on April 16, 2026, under the same symbol “NMTC” but with a new CUSIP Number, 64130M308.
Regaining compliance with Nasdaq’s listing requirements is crucial for NeuroOne as it ensures continued access to public capital markets, which is vital for the company’s ongoing operations and growth initiatives. NeuroOne is a medical technology company focused on improving surgical care for patients with neurological disorders. The company markets a minimally invasive, high-definition electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System (for brain), and OneRF Trigeminal Nerve Ablation System. These products aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering both diagnostic and therapeutic functions.
Additionally, NeuroOne is engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs. The company’s ability to maintain its Nasdaq listing supports these research efforts and its mission to transform the surgical diagnosis and treatment of neurological disorders. For more information, visit nmtc1.com.
